SYN1226022

SynDRA canonical compound SYN1226022 — structure-anchored drug synonym record

Clinical phase	Preclinical
Primary target(s)	MAPK14 \| RET \| TNF
Mechanism of action	p38 MAPK inhibitor

Bioactivity evidence (ChEMBL activities table — not curator-asserted)

MAPK13

Cross-references

PubChem CID: 25060093
ChEMBL: CHEMBL2087742

Synonyms

AL-8697
AL8697
MFCD28133371
orb1310012
SCHEMBL3610415
SCHEMBL31110558
C21H21F3N4O
AC9480
BDBM50420740
AKOS024458328
NCGC00387189-01
NCGC00387189-02
DA-70666
MS-26852
SY263536
HY-108645
CS-0029380
T10277

Look up SYN1226022 in the interactive SynDRA portal →